MWMengying Wei

Mengying Wei

*This is an algorithmically generated author record based on publicly available information.

Mengying Wei has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Guodong Yang

    Department of Biochemistry and Molecular Biology, the Fourth Military Medical University, Xi'an, China

    4 shared publications
  • Yan Dong

    State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology

    3 shared publications
  • Lijun Yuan

    Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi’an, China

    2 shared publications
  • Zhelong Li

    Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi'an, China

    2 shared publications
  • Zhuo Wan

    Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China

    2 shared publications
  • Guangsheng Wu

    Department of Stomatology, Qingdao Special Servicemen Recuperation Center of PLA Navy, No. 18 Yueyang Road, Qingdao 266071, China

    1 shared publication

Latest Publications

  • EV-Functionalized Fish Scale Scaffold Leverages Topographic and Biochemical Cues for Enhanced Bone Regeneration

    by Xuechun Dong, Zhihong Feng, Guangsheng Wu, Zhujun Yang, Ziyu Zeng, Yaqi Quan, Liang Kong, Yan Hou, Yan Dong, Mengying Wei, et al.

    The repair of critical-size bone defects remains clinically challenging, largely owing to the limited homing and osteogenic capacity of endogenous bone marrow mesenchymal stem cells (BMSCs). To address this, we developed a cell-free strategy that combines a decellularized fish scale (DC-FS) scaffold with stem cell sheet-derived extracellular vesicles (CS-EVs). This design leverages the scale's innate microgrooved topography for directional cell guidance while loading CS-EVs to provide sustained pro-osteogenic cues. The resulting CS-EVs/DC-FS composite retained the intrinsic micro/nanoarchitecture and mineralized composition of the biological scaffold and permitted controlled EVs release. The scaffold promoted directional migration, adhesion, and osteogenic differentiation of BMSCs in vitro, upregulating key markers including RUNX2, OPN, and BMP2. Mechanistically, EV-derived miRNAs, notably miR-146a-5p, were associated with activation of the Sirt1/Wnt/β-catenin signaling pathway. In a rat critical-size calvarial defect model, CS-EVs/DC-FS accelerated bone deposition, improved trabecular microstructure, and enhanced overall regeneration quality. This study establishes a topography-guided and EV-mediated strategy for bone regeneration, offering an integrated nature-derived solution for reconstructing challenging maxillofacial and orthopedic bone defects.

  • “All-in-One” Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia

    by Ruiyan Mei, Zhuo Wan, Zhelong Li, Mengying Wei, Weiwei Qin, Lijun Yuan, Li Liu, Guodong Yang

    Exosomes serve as a promising therapeutic nanoplatform. However, the exosomes produced by donor cells are a heterogeneous group, with only a small portion having high therapeutic efficacy. Specific isolation of the subpopulation with high efficacy is important for lowering the dose and minimizing toxicity. In this study, we loaded target mRNA and displayed specific Flag in engineered exosomes simultaneously. Briefly, the donor cells were transfected with plasmid expressing a fusion protein Flag-TCS-PTGFRN-CTSL-MCP, namely, exosome sorter. During biogenesis, the RNA-binding motif MCP can specifically bind with MS2-containing RNA and sort the target RNA into the lumen of exosomes. Anti-Flag magnetic beads can capture and thus purify the engineered exosomes via recognition of the Flag on the surface of exosomes. After purification, the Flag could be cleaved by thrombin treatment while MCP can be separated from the fusion protein by CTSL autocleavage upon exosome acidification, minimizing the side effects and augmenting the therapeutic effects. By the proof-of-concept experiment, the exosome sorter-based "all-in-one" strategy was confirmed effective in both the encapsulation of therapeutic mRNA (Ldlr-MS2) into exosomes and the subsequent purification. The purified Ldlr-MS2-containing exosomes had much higher efficacy in alleviating atherosclerosis, in comparison with the bulk exosomes, confirming the advantage of the proposed "all-in-one" strategy.


  • Open Access

    Smart exosomes with lymph node homing and immune-amplifying capacities for enhanced immunotherapy of metastatic breast cancer

    by Panpan Ji, Zheng Yang, Hua Li, Mengying Wei, Guodong Yang, Helin Xing, Qiuyun Li


  • Selective Encapsulation of Therapeutic mRNA in Engineered Extracellular Vesicles by DNA Aptamer

    by Siyan Zhang, Yan Dong, Yixiao Wang, Wenqi Sun, Mengying Wei, Lijun Yuan, Guodong Yang

    Extracellular vesicles (EV)-based delivery of therapeutic mRNAs is challenged by the low loading efficiency. In this study, we designed a DNA aptamer consisting of two parts: the single strand part recognized the AUG region of target mRNA, preventing mRNA from translation and ribosome assembly; and the double strand part containing the elements recognized by the CD9-ZF (zinc finger) motifs, sorting DNA aptamer-mRNA complex into CD9-ZF engineered EVs. In vitro and in vivo studies revealed that the system could efficiently load functional mRNAs to the EVs. Furthermore, adipose specific delivery of loaded Pgc1α mRNA via the strategy could efficiently induce white adipocyte browning. Similarly, delivery of interleukin-10 (Il-10) mRNA via the strategy had potent anti-inflammatory effect in inflammatory bowel disease (IBD) mouse model. Together, our study has proposed an efficient strategy to load therapeutic mRNAs of interest into EVs, which could be used as a promising strategy for gene therapy.


  • Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice

    by Mengying Wei, Xiaotong Gao, Lijun Liu, Zhelong Li, Zhuo Wan, Yan Dong, Xutao Chen, Yu Niu, Jian Zhang, Guodong Yang

    A pioneering epidemic study has revealed a strong association between obesity and the risk of colitis. In this study, a high fat diet was found to significantly aggravate colitis induced by dextran sulfate sodium (DSS). Meanwhile, a high fat diet changed the miRNA profile of the visceral adipose exosomes, switching the exosomes from anti-inflammatory to a pro-inflammatory phenotype. Strikingly, these inflammatory exosomes efficiently circulated into the lamina propria of the intestine, while these exosomes predisposed the intestine to inflammation via promoting macrophage M1 polarization. Mechanistically, the exosomes promoted M1 differentiation at least partially via transferring pro-inflammatory miRNAs, such as miR-155. Moreover, exosome-mediated miR-155 inhibitor delivery significantly prevented DSS-induced colitis. Together, the study has revealed an exosomal pathway of how obesity aggravates colitis and proposes an exosome-based intervention strategy for colitis management.